Table 1

Number and incidence (%) of individuals who develop R2 (preproliferative retinopathy), R3A (active proliferative retinopathy), M1 (diabetic maculopathy) or any of R2, R3A or M1, split up by sex and type of diabetes

Type IType II
Men (%)252 (51.9)5211 (56.6)
Total (%)486 (5.0)9201 (95.0)
annualbiennialannualbiennial
Men
 Developed R2 (%)22 (8.7)35 (13.9)69 (1.3)110 (2.1)
 Developed R3A (%)15 (6.0)17 (6.7)25 (0.5)45 (0.9)
 Developed M1 (%)23 (9.1)36 (14.3)114 (2.2)216 (4.1)
 Developed any above (%)41 (16.3)52 (20.6)153 (2.9)259 (5.0)
Women
 Developed R2 (%)15 (6.4)23 (9.8)32 (0.8)56 (1.4)
 Developed R3A (%)11 (4.7)14 (6.0)9 (0.2)14 (0.4)
 Developed M1 (%)17 (7.3)31 (13.2)89 (2.2)153 (3.8)
 Developed any above (%)30 (12.8)41 (17.5)107 (2.7)179 (4.5)
  • The results are shown for annual incidence (1 year) and biennial incidence (2 years).